Journal: Cancer immunology research
Article Title: Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
doi: 10.1158/2326-6066.CIR-17-0040
Figure Lengend Snippet: The effect of IL33 on the post-RT increase of Tregs in tumors. A, The time course of the IL33 level in tumor lysates from different time points (1, 6, 24, 48, and 72 hours and 7 days post RT) measured by ELISA (n = 5 per group). B, Experimental design. C57BL/6 mice were injected subcutaneously with 5 × 105 B16/F10 cells on day 0. Mice received 10 Gy of RT on day 7. Mice received a mAb to ST2 (200 μg/ mouse, Anti-ST2 Ab) or vehicle intraperitoneally (i.p.) every 3 days, starting 1 day before RT. Tumors, DLNs, and spleens were harvested on day 14. C, Tumor growth curves of vehicle control- (dashed line) versus ST2 Ab-treated mice (solid line), with or without radiation (black or red, respectively). D, Representative flow plot of TIL-Tregs. E and F, Quantitative scatter plots of % Foxp3+ cells of tumor-infiltrating CD4+ cells (E), and the absolute number of TIL-Tregs per gram tumor weight (F) in ST2 Ab-treated versus vehicle-treated group (n = 5 per group, repeated ×2). Error bars, SEM; ***, P < 0.001; **, P < 0.01; *, P < 0.05, determined by two-way ANOVA (A, C), and an unpaired Student t test (E, F).
Article Snippet: Mouse anti-ST2/IL-33 R monoclonal antibody (Clone 245707, R&D) was diluted in PBS and administrated intraperitoneally at a concentration of 200 μg in a volume of 100 μL per mouse every 3 days ( 25 ), starting 1 day before RT, for a total of three doses.
Techniques: Enzyme-linked Immunosorbent Assay, Injection